Notice & News
Streamline your CRISPR workflow with the AccuCleave T7CE Kit. This kit uses a rigorously tested heteroduplex assay to quickly identify gene editing events. Paired with the Fragment Analyzer™ Automated CE System, the AccuCleave T7CE Kit provides a high throughput screening solution with unparalleled precision and accuracy.
An accurate, high-throughput enzymatic screening method greatly enhances the efficiency of CRISPR workflows, minimizing the time and cost of NGS screening. The heteroduplex assay in the AccuCleave T7CE Kit quickly and efficiently identifies positive clones and approximates zygosity. Visualization of these results is carried out with the CRISPR Gel Discovery Kit (DNF-910-1000CP) on the Fragment Analyzer™
Figure 1. Visualization of AccuCleave T7CE assay using the CRISPR Gel Discovery Kit (DNF-910-1000CP) on the Fragment AnalyzerTM Automated CE System. Data analysis performed using PROSize Data Analysis Software to determine percent cleaved and zygosity.
Analysis in PROSize® Data Analysis Software enables the determination of percent cleaved and approximation of zygosity. In a 2n system, CRISPR mutations have three potential zygosities:
Further downstream analysis with NGS or Sanger Sequencing is necessary to characterize the exact nature of the gene editing events.